193 related articles for article (PubMed ID: 23939902)
1. Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.
Noordeen F; Vaillant A; Jilbert AR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5291-8. PubMed ID: 23939902
[TBL] [Abstract][Full Text] [Related]
2. Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.
Noordeen F; Vaillant A; Jilbert AR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5299-306. PubMed ID: 23939904
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
Guillot C; Martel N; Berby F; Bordes I; Hantz O; Blanchet M; Sureau C; Vaillant A; Chemin I
PLoS One; 2017; 12(6):e0179697. PubMed ID: 28636622
[TBL] [Abstract][Full Text] [Related]
4. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
Beilstein F; Blanchet M; Vaillant A; Sureau C
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
Noordeen F; Scougall CA; Grosse A; Qiao Q; Ajilian BB; Reaiche-Miller G; Finnie J; Werner M; Broering R; Schlaak JF; Vaillant A; Jilbert AR
PLoS One; 2015; 10(11):e0140909. PubMed ID: 26560490
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
8. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N; Civitico G; Wang YY; Guo KJ; Birch C; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):82-9. PubMed ID: 2388048
[TBL] [Abstract][Full Text] [Related]
9. Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry.
Matsumura T; Hu Z; Kato T; Dreux M; Zhang YY; Imamura M; Hiraga N; Juteau JM; Cosset FL; Chayama K; Vaillant A; Liang TJ
Gastroenterology; 2009 Aug; 137(2):673-81. PubMed ID: 19394333
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of duck hepatitis B virus infection by lysosomotropic agents.
Offensperger WB; Offensperger S; Walter E; Blum HE; Gerok W
Virology; 1991 Jul; 183(1):415-8. PubMed ID: 2053292
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection.
Vaillant A
Antiviral Res; 2016 Sep; 133():32-40. PubMed ID: 27400989
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
Schröder I; Holmgren B; Oberg M; Löfgren B
Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hepatocyteprotective and anti-hepatitis B virus properties of Cichoric acid from Cichorium intybus leaves in cell culture.
Zhang HL; Dai LH; Wu YH; Yu XP; Zhang YY; Guan RF; Liu T; Zhao J
Biol Pharm Bull; 2014; 37(7):1214-20. PubMed ID: 24759764
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine.
Zhang P; Zhai S; Chang J; Guo JT
Virol Sin; 2018 Dec; 33(6):538-544. PubMed ID: 30421112
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
20. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
